Evidence map›Paper›PMID 22183951›Full record

ArticleHepatology (Baltimore, Md.)2012

A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A-mediated translation and virus production.

Ronik Khachatoorian, Vaithilingaraja Arumugaswami, Piotr Ruchala, Santanu Raychaudhuri, Eden M Maloney, Edna Miao, Asim Dasgupta, Samuel W French

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection.International journal of molecular sciences · 2021
    Review
  4. Review
  5. Review
  6. Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly.International journal of antimicrobial agents · 2016
    Article
  7. Chaperones in hepatitis C virus infection.World journal of hepatology · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ronik KhachatoorianMolecular Biology Interdepartmental PhD Program, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Vaithilingaraja Arumugaswami
Piotr Ruchala
Santanu Raychaudhuri
Eden M Maloney
Edna Miao
Asim Dasgupta
Samuel W French
University of California, Los Angeles · USBlack AIDS Institute · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral InfectionR01DK090794 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRENCH, SAMUEL WHEELER · 2011 to 2015
$1.7M
The role of hepatitis C virus 5' untranslated region in virus morphogenesisR21AI084090 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DASGUPTA, ASIM · 2010 to 2011
$411k
NCATS NIH HHS UL1 TR000124NIAID NIH HHS R21 AI084090NIDDK NIH HHS R01 DK090794
6 · The paper itself

Abstract

unlabelledNS5A is a key regulator of the hepatitis C virus (HCV) life cycle including RNA replication, assembly, and translation. We and others have shown that NS5A augments HCV internal ribosomal entry site (IRES)-mediated translation. Furthermore, Quercetin treatment and heat shock protein (HSP) 70 knockdown inhibit the NS5A-driven augmentation of IRES-mediated translation and infectious virus production. We have also coimmunoprecipitated HSP70 with NS5A and demonstrated cellular colocalization, leading to the hypothesis that the NS5A/HSP70 complex formation is important for IRES-mediated translation. Here, we have identified the NS5A region responsible for complex formation through in vitro deletion analyses. Deletion of NS5A domains II and III failed to reduce HSP70 binding, whereas domain I deletion eliminated complex formation. NS5A domain I alone also bound HSP70. Deletion mapping of domain I identified the C-terminal 34 amino acids (C34) as the interaction site. Furthermore, addition of C34 to domains II and III restored complex formation. C34 expression significantly reduced intracellular viral protein levels, in contrast to same-size control peptides from other NS5A domains. C34 also competitively inhibited NS5A-augmented IRES-mediated translation, whereas controls did not. Triple-alanine scan mutagenesis determined that an exposed beta-sheet hairpin in C34 was primarily responsible for NS5A-augmented IRES-mediated translation. Moreover, treatment with a 10-amino acid peptide derivative of C34 suppressed NS5A-augmented IRES-mediated translation and significantly inhibited intracellular viral protein synthesis, with no associated cytotoxicity.

conclusionThese results support the hypothesis that the NS5A/HSP70 complex augments viral IRES-mediated translation, identify a sequence-specific hairpin element in NS5A responsible for complex formation, and demonstrate the functional significance of C34 hairpin-mediated NS5A/HSP70 interaction. Identification of this element may allow for further interrogation of NS5A-mediated IRES activity, sequence-specific HSP recognition, and rational drug design. (HEPATOLOGY 2012;55:1662-1672).

Indexed as

Binding SitesCells, CulturedDrug DesignHSP70 Heat-Shock ProteinsHumansPeptide FragmentsProtein BiosynthesisProtein Structure, TertiaryRibosomesRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsVirus ReplicationHSP70 Heat-Shock ProteinsNS-5 protein, hepatitis C virusPeptide FragmentsRNA-Dependent RNA PolymeraseViral Nonstructural Proteins

Identifiers

PMID22183951
PMCPMC3345309
OpenAlexW1967103826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.